Literature DB >> 18691680

Plasminogen activators are involved in the degradation of bone by osteoclasts.

Vincent Everts1, Evis Daci, Wikky Tigchelaar-Gutter, Kees A Hoeben, Sophie Torrekens, Geert Carmeliet, Wouter Beertsen.   

Abstract

Osteoclastic bone degradation depends on the activity of several proteolytic enzymes, in particular to those belonging to the classes of cysteine proteinases and matrix metalloproteinases (MMPs). Yet, several findings suggest that the two types of plasminogen activators (PA), the tissue- and urokinase-type PA (tPA and uPA, respectively) are also involved in this process. To investigate the involvement of these enzymes in osteoclast-mediated bone matrix digestion, we analyzed bone explants of mice that were deficient for both tPA and uPA and compared them to wild type mice. The number of osteoclasts as well as their ultrastructural appearance was similar for both genotypes. Next, calvarial and metatarsal bone explants were cultured for 6 or 24 h in the presence of selective inhibitors of cysteine proteinases or MMPs and the effect on osteoclast-mediated bone matrix degradation was assessed. Inhibition of the activity of cysteine proteinases in explants of control mice resulted in massive areas of non-digested demineralized bone matrix adjacent to the ruffled border of osteoclasts, an effect already maximal after 6 h. However, at that time point these demineralized areas were not observed in bone explants from uPA/tPA deficient mice. After prolonged culturing (24 h), a comparable amount of demineralized bone matrix adjacent to actively resorbing osteoclasts was observed in the two genotypes, suggesting that degradation was delayed in uPA/tPA deficient bones. The activity of cysteine proteinases as assessed in bone extracts, proved to be higher in extracts from uPA/tPA(-/-) bones. Immunolocalization of the integrin alpha(v)beta(3) of in vitro generated osteoclasts demonstrated a more diffuse labeling of osteoclasts derived from uPA/tPA(-/-) mice. Taken together, our data indicate that the PAs play a hitherto unrecognized role in osteoclast-mediated bone digestion. The present findings suggest that the PAs are involved in the initial steps of bone degradation, probably by a proper integrin-dependent attachment to bone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691680     DOI: 10.1016/j.bone.2008.07.004

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

1.  RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implications.

Authors:  Antonio Garcia-Gomez; Enrique M Ocio; Atanasio Pandiella; Jesús F San Miguel; Mercedes Garayoa
Journal:  Invest New Drugs       Date:  2012-07-07       Impact factor: 3.850

2.  Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function.

Authors:  Yosuke Kanno; Akira Ishisaki; Eri Kawashita; Naoyuki Chosa; Keiichi Nakajima; Tatsuji Nishihara; Kuniaki Toyoshima; Kiyotaka Okada; Shigeru Ueshima; Kenji Matsushita; Osamu Matsuo; Hiroyuki Matsuno
Journal:  J Biol Chem       Date:  2011-01-14       Impact factor: 5.157

3.  Plasminogen Regulates Fracture Repair by Promoting the Functions of Periosteal Mesenchymal Progenitors.

Authors:  Luqiang Wang; Lutian Yao; Hao Duan; Fan Yang; Maohuan Lin; Rongxin Zhang; Zhenqiang He; Jaimo Ahn; Yi Fan; Ling Qin; Yanqing Gong
Journal:  J Bone Miner Res       Date:  2021-09-08       Impact factor: 6.741

4.  Urokinase plasminogen activator gene deficiency inhibits fracture cartilage remodeling.

Authors:  Nicoleta L Popa; Jon E Wergedal; K-H William Lau; Subburaman Mohan; Charles H Rundle
Journal:  J Bone Miner Metab       Date:  2013-05-23       Impact factor: 2.626

5.  Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification.

Authors:  Masato Yuasa; Nicholas A Mignemi; Jeffry S Nyman; Craig L Duvall; Herbert S Schwartz; Atsushi Okawa; Toshitaka Yoshii; Gourab Bhattacharjee; Chenguang Zhao; Jesse E Bible; William T Obremskey; Matthew J Flick; Jay L Degen; Joey V Barnett; Justin M M Cates; Jonathan G Schoenecker
Journal:  J Clin Invest       Date:  2015-07-27       Impact factor: 14.808

Review 6.  Roles of fibrinolytic factors in the alterations in bone marrow hematopoietic stem/progenitor cells during bone repair.

Authors:  Kiyotaka Okada; Minoru Nishioka; Hiroshi Kaji
Journal:  Inflamm Regen       Date:  2020-09-16

7.  Cavin-1/PTRF alters prostate cancer cell-derived extracellular vesicle content and internalization to attenuate extracellular vesicle-mediated osteoclastogenesis and osteoblast proliferation.

Authors:  Kerry L Inder; Jayde E Ruelcke; Lara Petelin; Hyeongsun Moon; Eunju Choi; James Rae; Antje Blumenthal; Dietmar Hutmacher; Nicholas A Saunders; Jennifer L Stow; Robert G Parton; Michelle M Hill
Journal:  J Extracell Vesicles       Date:  2014-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.